Komori
Occurring Fact6197Solasto CorporationInformation and Communications, Services and Others

Notice Regarding the Recording of Extraordinary Loss

In the consolidated financial results for fiscal 2025, we recognized an extraordinary loss of ¥1,148 million. This comprised impairment losses of ¥751 million on certain nursing care facilities and childcare facilities, and ¥397 million in tender offer-related expenses.

Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
1148
¥ million
Wording
Definitive
How definitive the wording is.

Recognition of an extraordinary loss

Subject Entity

Solasto Corporation (the Company)

Target Locations / Products

Certain nursing care facilities and childcare facilities

This disclosure05/13/2026
Cause

Profitability declined at certain nursing care facilities and childcare facilities, and we determined that recovery of the investments could not be expected. In addition, advisory fees and other expenses were incurred in connection with the tender offer by MP-2605株式会社 for the Company's common shares.

Amount of Impact on Business Performance

¥1,148 million (extraordinary loss). This comprised impairment losses of ¥751 million and tender offer-related expenses of ¥397 million.

Accounting period in which recognized

The fourth quarter of fiscal 2025 (1 April 2025 to 31 March 2026), and the consolidated financial results for fiscal 2025

Related procedures

Type

Tender offer

Event that occurred
ItemDetails
Event nameRecognition of an extraordinary loss
Subject EntitySolasto Corporation (the Company)
Target Locations / ProductsCertain nursing care facilities and childcare facilities
CauseProfitability declined at certain nursing care facilities and childcare facilities, and we determined that recovery of the investments could not be expected. In addition, advisory fees and other expenses were incurred in connection with the tender offer by MP-2605株式会社 for the Company's common shares.
Amount of Impact on Business Performance¥1,148 million (extraordinary loss). This comprised impairment losses of ¥751 million and tender offer-related expenses of ¥397 million.
Accounting period in which recognizedThe fourth quarter of fiscal 2025 (1 April 2025 to 31 March 2026), and the consolidated financial results for fiscal 2025
Type of litigation or proceedingTender offer
Items this document does not state (18)
Date of occurrenceDate recognized / date notice receivedImpact on Earnings ForecastCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changeOutlookPlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because profitability declined at certain nursing care facilities and childcare facilities, and we determined that recovery of the investments could not be expected. In addition, advisory fees and other expenses were incurred in connection with the tender offer by MP-2605株式会社.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Recording of Extraordinary Loss | Solasto Corporation (6197) timely disclosure | Komori